CAS 3374-22-9|DL-CYSTEINE (1-13C)
| Common Name | DL-CYSTEINE (1-13C) | ||
|---|---|---|---|
| CAS Number | 3374-22-9 | Molecular Weight | 121.158 |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 293.9±35.0 °C at 760 mmHg |
| Molecular Formula | C3H7NO2S | Melting Point | 225ºC (dec.) |
| MSDS | ChineseUSA | Flash Point | 131.5±25.9 °C |
| Symbol | GHS05, GHS07 | Signal Word | Danger |
Names
| Name | cysteine |
|---|---|
| Synonym | More Synonyms |
DL-CYSTEINE (1-13C) BiologicalActivity
| Description | 2-Amino-3-mercaptopropanoic acid is a cysteine derivative[1]. |
|---|---|
| Related Catalog | Research Areas >>OthersSignaling Pathways >>Others >>Others |
| In Vitro | Amino acids and amino acid derivatives have been commercially used as ergogenic supplements. They influence the secretion of anabolic hormones, supply of fuel during exercise, mental performance during stress related tasks and prevent exercise induced muscle damage. They are recognized to be beneficial as ergogenic dietary substances[1]. |
| References | [1]. Luckose F, et al. Effects of amino acid derivatives on physical, mental, and physiological activities. Crit Rev Food Sci Nutr. 2015;55(13):1793-807. |
Chemical & Physical Properties
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 293.9±35.0 °C at 760 mmHg |
| Melting Point | 225ºC (dec.) |
| Molecular Formula | C3H7NO2S |
| Molecular Weight | 121.158 |
| Flash Point | 131.5±25.9 °C |
| Exact Mass | 121.019745 |
| PSA | 102.12000 |
| LogP | 0.23 |
| Vapour Pressure | 0.0±1.3 mmHg at 25°C |
| Index of Refraction | 1.550 |
| InChIKey | XUJNEKJLAYXESH-UHFFFAOYSA-N |
| SMILES | NC(CS)C(=O)O |
| Stability | Stable. Incompatible with strong oxidizing agents, |
Toxicological Information
CHEMICAL IDENTIFICATION |
ACUTE TOXICITY DATA - TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 1250 mg/kg/2D-I
- TOXIC EFFECTS :
- Liver - other changes Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - phosphatases Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - dehydrogenases
MUTATION DATA - TYPE OF TEST :
- Phage inhibition capacity
- TEST SYSTEM :
- Bacteria - Escherichia coli
- DOSE/DURATION :
- 5 mg/L
- REFERENCE :
- APMBAY Applied Microbiology. (Washington, DC) V.1-30, 1953-75. For publisher information, see AEMIDF. Volume(issue)/page/year: 12,234,1964
- TYPE OF TEST :
- Phage inhibition capacity
- TEST SYSTEM :
- Bacteria - Escherichia coli
- DOSE/DURATION :
- 5 mg/L
- REFERENCE :
- APMBAY Applied Microbiology. (Washington, DC) V.1-30, 1953-75. For publisher information, see AEMIDF. Volume(issue)/page/year: 12,234,1964
Safety Information
| Symbol | GHS05, GHS07 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H302-H314-H335 |
| Precautionary Statements | P280-P301 + P312 + P330-P303 + P361 + P353-P304 + P340 + P310-P305 + P351 + P338 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xn,Xi |
| Risk Phrases | R20/21/22 |
| Safety Phrases | 26-36/37/39 |
| RIDADR | UN 2923 6.1(8) / PGIII |
| WGK Germany | 3 |
| RTECS | HA1595000 |
| HS Code | 2930909090 |
Customs
| HS Code | 2930909090 |
|---|---|
| Summary | 2930909090. other organo-sulphur compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
Articles467
More Articles| A survey of the interactome of Kaposi's sarcoma-associated herpesvirus ORF45 revealed its binding to viral ORF33 and cellular USP7, resulting in stabilization of ORF33 that is required for production of progeny viruses. J. Virol. 89(9) , 4918-31, (2015) The ORF45 protein of Kaposi's sarcoma-associated herpesvirus (KSHV) is a gammaherpesvirus-specific immediate-early tegument protein. Our previous studies have revealed its crucial roles in both early ... | |
| Insight into PreImplantation Factor (PIF*) mechanism for embryo protection and development: target oxidative stress and protein misfolding (PDI and HSP) through essential RIKP [corrected] binding site. PLoS ONE 9(7) , e100263, (2014) Endogenous PIF, upon which embryo development is dependent, is secreted only by viable mammalian embryos, and absent in non-viable ones. Synthetic PIF (sPIF) administration promotes singly cultured em... | |
| Hepatitis E virus (HEV) protease: a chymotrypsin-like enzyme that processes both non-structural (pORF1) and capsid (pORF2) protein. J. Gen. Virol. 95(Pt 8) , 1689-700, (2014) Hepatitis E virus (HEV), a major cause of acute viral hepatitis across the world, is a non-enveloped, plus-strand RNA virus. Its genome codes three proteins, pORF1 (multifunctional polyprotein), pORF2... |
Synonyms
| dl-2-amino-3-mercaptopropionic acid |
| MFCD00004881 |
| Cysteine |
| 2-Amino-3-mercaptopropanoic acid |
| DL-Cysteine |
| 2-amino-3-sulfopropionic acid |
| hydrogen cysteinate |
| CYSTEINE, DL- |
| 2-amino-3-sulfanylpropanoic acid |
| 2-Amino-3-mercaptopropionic acid |
| 2-Amino-3-mercaptopropionicacid |
| EINECS 222-160-2 |
